Biology of ischemic and toxic renal tubular cell injury: Role of nitric oxide and the inflammatory response

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 3, 1998, Pages 289-295

  Lieberthal, Wilfred ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CELL ADHESION MOLECULE; CYCLIN DEPENDENT KINASE; CYCLINE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HEAT SHOCK PROTEIN; INTEGRIN; LEUKOTRIENE B4; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN DIOXIDE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; PROTEIN; SELECTIN; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; TRANSCRIPTION FACTOR;

ACUTE KIDNEY FAILURE; ARTICLE; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; INFLAMMATION; ISCHEMIA; KIDNEY TUBULE DAMAGE; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; T LYMPHOCYTE;

EID: 0031838272     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199805000-00009     Document Type: Article

References (71)

1. Yuan CM, Bohen EM, Musio F, Carome MA. Sublethal heat shock and cyclosporine exposure produce tolerance against subsequent cyclosporine exposure. Am J Physiol 1996; 271:F571-F578.
2. Borkan S, Wang Y-H, Lieberthal W, Burke P, Schwartz J. Heat stress ameliorates ATP depletion-induced sublethal injury in mouse proximal tubule cells. Am J Physiol 1997; 272:F347-F355.
3. Safirstein R. Renal stress response and acute renal failure. Adv Ren Replace Ther 1997; 4:38-42.
4. Humes HD, Liu EW. Renal tubule cell repair following acute renal injury. Miner Electrolyte Metab 1997; 21:353-365.
5. DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272:F290-F298.
6. Joannidis M, Cantley LG, Spokes K, Stuart-Tilley AK, Alper SL, Epstein FH. Modulation of c-fos and egr-1 expression in the isolated perfused kidney by agents that alter tubular work. Kidney Int 1997; 52:130-139.
7. Park SK, Kang MJ, Kim W, Koh GY. Renal tubule regeneration after ischemic injury is coupled to the up-regulation and activation of cyclins and cyclin-dependent kinases. Kidney Int 1997; 52:706-714.
8. Franklin SC, Moulton M, Sicard GA, Hammerman MR, Miller SB. Insulin-like growth factor 1 preserves renal function postoperatively. Am J Physiol 1997; 272:F257-F259.
9. Johnson DW, Saunders HJ, Brew BK, Ganesan A, Baxter RC, Poronnik P, et al. Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-1 axis. Kidney Int 1997; 52:1486-1496.
10. Cantley L. Growth factors and the kidney: regulation of epithelial movement and morphogenesis. Am J Physiol 1996; 271:F1103-F1113. This is an excellent review of the cellular biology of renal tubular cell growth factors.
11. Ichimura T, Finch P, Zhang G, Kan M, Stevens J. Induction of FGF-7 after kidney damage: a possible paracrine mechanism for tubule repair. Am J Physiol 1996; 271:F979-F976.
12. Harris RC. Growth factors and cylokines in acute renal failure. Adv Ren Replace Ther 1997; 4:43-53.
13. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. α-Melanocyte-stimulating hormone protects against acute renal injury after ischemia in mice and rats. J Clin Invest 1997; 99:1165-1172. A novel and important study is presented, in which the dramatic ameliorative effect of α-MSH in ARF is reported and the potential mechanisms involved are thoughtfully discussed.
14. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic renal failure. Kidney Int 1997; 51:1463-1468.
15. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 costimulatory pathway in experimental cold ischemia-reperfusion injury. J Clin Invest 1997; 100:1199-1203. This study demonstrates for the first time that inhibition of T-cell activation by blockade of the B7 costimulatory pathway ameliorates ischemic ARF in the absence of an immunologic stimulus provided by alloantigen.
16. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cylokine response: evidence for in-duction of interferon-γ, transforming growth factor-β1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59:565-572.
17. Kelly K, Williams W, Colvin R, Bonventre J. Antibody to intercellular adhesion molecule-1 protects against ischemic injury. Proc Natl Acad Sci USA 1994; 91:812-815.
18. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade on ischemia/reperfusion injury of the rat kidney: inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99:2682-2690 This important study demonstrates a role for P-selectin in ischemic ARF.
19. Kohan D. Endothelins in the normal and diseased kidney. Am J Kidney Dis 1997; 29:2-26. A useful general review is presented of the role of endothelin in a number of renal diseases, which includes a discussion of the role of endothelin in ARF.
20. Webb D. Physiologic role of the endothelin system in human cardiovascular and renal hemodynamics. Curr Opin Nephrol Hypertens 1997; 6:69-73.
21. Espinosa G, Farré AL, Cernadas MR, Manzarbeitia F, Tan D, Diguini E, et al. Role of endothelin in the pathophysiology of renal ischemia-reperfusion in normal rabbits. Kidney Int 1996; 50:776-782.
22. B endothelin antagonist, L-754, 142, after aortic cross-clamping in the dog. J Am Soc Nephrol 1997; 8:1061-1071.
23. Caramelo C. Farré AL, Riesco A, Casado S. Role of endothelin-1 in the activation of polymorphonuclear leukocytes. Kidney Int 1997; 52 (suppl 61):S56-S59. This paper provides a discussion of the relatively novel concept that endothelin activates leukocytes and promotes leukocyte-induced injury.
24. Rabb H, Medniola C, Dietz J, Saba S, Issekutz T, Abanilla F, et al. Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physiol 1994; 267:F1052-F1058.
25. Rabb H, Mendiola CC, Saba SR, Dietz JR, Smith CW, Bonventre JV, Ramirez G. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 1995; 211:67-73.
26. Linas SL, Whittenburg D, Parsons PR, Repine JE. Ischemia increases neutrophil retention and worsens acute renal failure: role of oxygen metabolites and ICAM-1. Kidney Int 1995; 48:1584-1591.
27. Rabb H. Cell adhesion molecules and the kidney. Am J Kidney Dis 1994; 23:155-165.
28. Brady H. Leukocyte adhesion molecules and kidney diseases. Kidney Int 1994; 45:1285-1290.
29. Haller H, Dragun D, Miethke A, Park JK, Weis A, Lippoldt A, et al. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 1996; 50:473-480.
30. Kelly K, Williams W, Colvin R, Meehan S, Springer T, Guttiérrez-Ramos J-C, Bonventre J. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97:1056-1063. The resistance of ICAM-1 knockout mice to ischemic ARF confirms the findings of previous experiments using neutralizing anti-ICAM-1 antibodies that ICAM-mediated leukocyte adhesion is important in the pathophysiology of ischemic ARF.
31. Rabb H, Ramirez G, Saba SR, Reynolds D, Xu J, Flavell R, Antonia S. Renal ischemia-reperfusion injury in L-selectin-deficient mice. Am J Physiol 1996; 271:F408-F413.
32. Rabb H, Mendiola CC, Saga S, Dietz J, Smith C, Bonventre J, et al. Antibodies to P-selectin and ICAM-1 protect kidneys from ischemic-reperfusion injury [abstract]. J Am Soc Nephrol 1994; 907. This is the first report demonstrating that blockade of P-selectin mediated adhesion ameliorates ischemic ARF.
33. Bonventre JV, Colvin RB. Adhesion molecules in renal disease. Curr Opin Nephrol Hypertens 1996; 5:254-261.
34. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391:393-396. This is a highly novel and important report that myeloperoxidase mediates the conversion of nitrite to peroxynitrite. It indicates for the first time that nitrite, an inert byproduct of NO metabolism, can represent an abundant source of peroxynitrite production by leukocytes.
35. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995; 332:647-655.
36. Epstein FH. Oxygen and renal metabolism. Kidney Int 1997; 51:381-385.
37. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996; 94:3271-3275.
38. Liss P, Nygren A, Olsson U, Ulfendahl H, Erikson U. Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int 1996; 49:1268-1275.
39. Kelly K, Tolkoff-Rubin N, Rubin R, Williams W, Meehan S, Meschter C, et al. An oral platelet activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury. Am J Physiol 1996; 271:F1061-F1067. This is a study that provides convincing evidence of the importance of PAF in ARF.
40. Chandraker A, Takada M, Nadeau KC, Peach R, Tilney NL, Sayegh MH. CD28-B7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int 1997; 52:1678-1684.
41. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100:2417-2423. A superb discussion of the role of iNOS in modulating the inflammatory response. This review stresses that the effect of increased iNOS expression during infection is potentially 'dichotomous', improving host survival in some situations and having deleterious effects in others.
42. Peer G, Blum M, Jaina A. Nitric oxide and acute renal failure. Naphron 1996; 73:375-381. This review stresses the potential beneficial and harmful effects of NO in ARF.
43. Mayer B, Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biol Sci 1997; 22:477-481. A succinct but thorough review is presented of recent advances in our understanding of the chemistry of NO, emphasizing the mechanisms of NO-induced cytotoxicity
44. Cook T. Nitric oxide synthases and the role of nitric oxide in acute renal failure. In: Stein J, Goligorsky M (editors). Acute renal failure: new concepts and therapeutic strategies. New York: Churchill Livingstone; 1995. pp. 118-142.
45. Weigert AL, Martin P-Y, Schrier RW. Vascular hyporesponsiveness in cirrhotic rats; role of different nitrix oxide isoforms. Kidney Int 1997; 52 (suppl 61):S41-S44.
46. Yu L, Gengaro P, Niederberger M, Burke T, Schrier R. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 1994; 91:1691-1695.
47. Bachmann S, Bosse H, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol 1995; 268:F885-F891.
48. Raij L, Baylis C. Glomerular actions of nitric oxide. Kidney Int 1995; 48:20-32.
49. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, Kubes P. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 1997; 11:955-964. This is an important in-vivo demonstration of the role of NO in modulating the inflammatory component of ARF.
50. Freedman J, Loscalzo J, Barnard M, Alpert C, Keaney J, Ad M. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997; 358-366.
51. Phelan MW, Faller DV. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. J Cell Physiol 1996; 167:469-476. This is novel demonstration that hypoxia inhibits expression of endothelial NOS in cultured endothelial cells.
52. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94:1069-1075.
53. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypertens 1996; 5:127-133. This is a useful discussion of current concepts of the pathophysiology of radiocontrast-induced ARF.
54. Heyman S, Fuchs S, Jaffe R, Shina A, Ellezian L, Brezis M, Rosen S. Renal microcirculation and tissue damage during acute ureteral obstruction in the rat: effect of saline infusion, indomethacin and radiocontrast. Kidney Int 1997; 51:653-663.
55. Erley CM, Heyne N, Burgert K, Langanke J, Risler T, Osswald H. Prevention of radiocontrast-induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency. J Am Soc Nephrol 1997; 8:1125-1132.
56. Arakawa K, Suzuki H, Naitoh M, Malsumoto A, Hayashi K, Matsuda H, et al. Role of adenosine in the renal response to contrast medium. Kidney Int 1996; 49:1199-1206.
57. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HW. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 1992; 89:11993-11997.
58. Edelstein CL, Ling H, Schrier RW. The nature of renal cell injury. Kidney Int 1997; 51:1341-1351.
59. Yaqoob M, Edelstein C, Weider E, Alkhunaizi A, Gengaro P, Nemenoff R, Schrier R. Nitric oxide kinetics during hypoxia in proximal tubules: effects of acidosis and glycine. Kidney Int 1996; 49:1314-1319. An important demonstration is provided of the role of NO in exacerbating hypoxic injury to renal tubular cells.
60. Traylor LA, Mayeux PR. Nitric oxide generation mediates lipid A-induced oxidant injury in renal proximal tubules. Arch Biochem Biophys 1997; 338:129-153.
61. Liu, Hock CE, Nagele R, Wong PY-K. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 1997; 272:H2327-H2336.
62. Peresleni T, Noiri E, Bahou W, Goligorsky M. Antisense oligodeoxy-nucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am J Physiol 1996; 270:F971-F977. This study indicates that iNOS is the predominant NOS isoform responsible for increased NO production and NO-mediated injury in renal tubular cells in culture subjected to an oxidative insult.
63. Noiri E, Pereslini T, Miller F, Goligorsky MS. In-vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996; 97:2377-2383. This study is the first to demonstrate that inhibiting tubular NO production while leaving eNOS and nNOS activity unaffected can ameliorate experimental ARF in vivo.
64. Ling H, Edelstein CL, Gengaro P, Martin P, Wangsiripaisan A, Partison T, et al. Inducible nitric oxide is the injurious isoform involved in hypoxia-induced mouse proximal tubule (PT) injury [abstract]. J Am Soc Nephrol 1997; 8:591A.
65. Kaboré AF, Denis M, Bergeron MG. Association of nitric oxide production by kidney proximal tubular cells in response to lipopolysaccharide and cytokines with cellular damage. Antimicrob Agents Chemother 1997; 41:557-562.
66. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271:C1424-C1437. A comprehensive and lucid review is presented of the complex chemistry involved in NO-induced cytotoxicity.
67. Mallozzi C, Stasi AMM, Minetti M. Peroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB J 1997; 11:1281-1290.
68. Linas S, Whirtenburg D, Repine JE. Nitric oxide prevents neutrophil mediated acute renal failure. Am J Physiol 1996; 272:F48-F54.
69. Chiao H, Foster S, Thomas R, Lipton JM, Star RA. α-Melanocyte-stimulating hormone reduces endotoxin induced liver inflammation. J Clin Invest 1996; 97:2038-2044. This is an impressive demonstration of the potent anti-inflammatory properties of α-MSH in vivo.
70. Catania A, Rajora N, Capsoni F, Star RA, Lipton J. The neuropeptide α-melanocyte-stimulating hormone has specific receptors on neutrophils and reduces chemotaxis in vivo. Peptides (Tarryt.) 1996; 17:675-669.
71. Star RA, Rajora N, Huang J, Chavez A, Catania A, Lipton J. Evidence of autocrine modulation of macrophage nitric oxide synthase by 3-melanocyte stimulating hormone. Proc Natt Acad Sci USA 1995; 92:8016-8020.